Copyright Reports & Markets. All rights reserved.

Global Antacid Tablet Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Antacid Tablet Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Antacid Tablet Market Size Growth Rate by Product
      • 1.4.2 Ca based
      • 1.4.3 Mg based
      • 1.4.4 Mixed
    • 1.5 Market by End User
      • 1.5.1 Global Antacid Tablet Market Size Growth Rate by End User
      • 1.5.2 In-Patient
      • 1.5.3 Out-Patient
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Antacid Tablet Market Size
      • 2.1.1 Global Antacid Tablet Revenue 2014-2025
      • 2.1.2 Global Antacid Tablet Sales 2014-2025
    • 2.2 Antacid Tablet Growth Rate by Regions
      • 2.2.1 Global Antacid Tablet Sales by Regions
      • 2.2.2 Global Antacid Tablet Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Antacid Tablet Sales by Manufacturers
      • 3.1.1 Antacid Tablet Sales by Manufacturers
      • 3.1.2 Antacid Tablet Sales Market Share by Manufacturers
      • 3.1.3 Global Antacid Tablet Market Concentration Ratio (CR5 and HHI)
    • 3.2 Antacid Tablet Revenue by Manufacturers
      • 3.2.1 Antacid Tablet Revenue by Manufacturers (2014-2019)
      • 3.2.2 Antacid Tablet Revenue Share by Manufacturers (2014-2019)
    • 3.3 Antacid Tablet Price by Manufacturers
    • 3.4 Antacid Tablet Manufacturing Base Distribution, Product Types
      • 3.4.1 Antacid Tablet Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Antacid Tablet Product Type
      • 3.4.3 Date of International Manufacturers Enter into Antacid Tablet Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Antacid Tablet Sales by Product
    • 4.2 Global Antacid Tablet Revenue by Product
    • 4.3 Antacid Tablet Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Antacid Tablet Breakdown Data by End User

    6 North America

    • 6.1 North America Antacid Tablet by Countries
      • 6.1.1 North America Antacid Tablet Sales by Countries
      • 6.1.2 North America Antacid Tablet Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Antacid Tablet by Product
    • 6.3 North America Antacid Tablet by End User

    7 Europe

    • 7.1 Europe Antacid Tablet by Countries
      • 7.1.1 Europe Antacid Tablet Sales by Countries
      • 7.1.2 Europe Antacid Tablet Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Antacid Tablet by Product
    • 7.3 Europe Antacid Tablet by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Antacid Tablet by Countries
      • 8.1.1 Asia Pacific Antacid Tablet Sales by Countries
      • 8.1.2 Asia Pacific Antacid Tablet Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Antacid Tablet by Product
    • 8.3 Asia Pacific Antacid Tablet by End User

    9 Central & South America

    • 9.1 Central & South America Antacid Tablet by Countries
      • 9.1.1 Central & South America Antacid Tablet Sales by Countries
      • 9.1.2 Central & South America Antacid Tablet Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Antacid Tablet by Product
    • 9.3 Central & South America Antacid Tablet by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Antacid Tablet by Countries
      • 10.1.1 Middle East and Africa Antacid Tablet Sales by Countries
      • 10.1.2 Middle East and Africa Antacid Tablet Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Antacid Tablet by Product
    • 10.3 Middle East and Africa Antacid Tablet by End User

    11 Company Profiles

    • 11.1 GSK
      • 11.1.1 GSK Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 GSK Antacid Tablet Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 GSK Antacid Tablet Products Offered
      • 11.1.5 GSK Recent Development
    • 11.2 Walmart（Equate）
      • 11.2.1 Walmart（Equate） Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Walmart（Equate） Antacid Tablet Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Walmart（Equate） Antacid Tablet Products Offered
      • 11.2.5 Walmart（Equate） Recent Development
    • 11.3 Boehringer Ingelheim Pharmaceuticals
      • 11.3.1 Boehringer Ingelheim Pharmaceuticals Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Boehringer Ingelheim Pharmaceuticals Antacid Tablet Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Boehringer Ingelheim Pharmaceuticals Antacid Tablet Products Offered
      • 11.3.5 Boehringer Ingelheim Pharmaceuticals Recent Development
    • 11.4 Chattem
      • 11.4.1 Chattem Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Chattem Antacid Tablet Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Chattem Antacid Tablet Products Offered
      • 11.4.5 Chattem Recent Development
    • 11.5 Bayer
      • 11.5.1 Bayer Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Bayer Antacid Tablet Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Bayer Antacid Tablet Products Offered
      • 11.5.5 Bayer Recent Development
    • 11.6 WellSpring Pharmaceutical Corporation
      • 11.6.1 WellSpring Pharmaceutical Corporation Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 WellSpring Pharmaceutical Corporation Antacid Tablet Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 WellSpring Pharmaceutical Corporation Antacid Tablet Products Offered
      • 11.6.5 WellSpring Pharmaceutical Corporation Recent Development
    • 11.7 Thornton & Ross Ltd
      • 11.7.1 Thornton & Ross Ltd Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Thornton & Ross Ltd Antacid Tablet Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Thornton & Ross Ltd Antacid Tablet Products Offered
      • 11.7.5 Thornton & Ross Ltd Recent Development
    • 11.8 PG
      • 11.8.1 PG Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 PG Antacid Tablet Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 PG Antacid Tablet Products Offered
      • 11.8.5 PG Recent Development
    • 11.9 McNeil Consumer Pharmaceuticals
      • 11.9.1 McNeil Consumer Pharmaceuticals Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 McNeil Consumer Pharmaceuticals Antacid Tablet Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 McNeil Consumer Pharmaceuticals Antacid Tablet Products Offered
      • 11.9.5 McNeil Consumer Pharmaceuticals Recent Development

    12 Future Forecast

    • 12.1 Antacid Tablet Market Forecast by Regions
      • 12.1.1 Global Antacid Tablet Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Antacid Tablet Revenue Forecast by Regions 2019-2025
    • 12.2 Antacid Tablet Market Forecast by Product
      • 12.2.1 Global Antacid Tablet Sales Forecast by Product 2019-2025
      • 12.2.2 Global Antacid Tablet Revenue Forecast by Product 2019-2025
    • 12.3 Antacid Tablet Market Forecast by End User
    • 12.4 North America Antacid Tablet Forecast
    • 12.5 Europe Antacid Tablet Forecast
    • 12.6 Asia Pacific Antacid Tablet Forecast
    • 12.7 Central & South America Antacid Tablet Forecast
    • 12.8 Middle East and Africa Antacid Tablet Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Antacid Tablet Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Antacid Tablet market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antacid Tablet market based on company, product type, end user and key regions.

      This report studies the global market size of Antacid Tablet in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antacid Tablet in these regions.
      This research report categorizes the global Antacid Tablet market by top players/brands, region, type and end user. This report also studies the global Antacid Tablet market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      GSK
      Walmart（Equate）
      Boehringer Ingelheim Pharmaceuticals
      Chattem
      Bayer
      WellSpring Pharmaceutical Corporation
      Thornton & Ross Ltd
      PG
      McNeil Consumer Pharmaceuticals

      Market size by Product
      Ca based
      Mg based
      Mixed
      Market size by End User
      In-Patient
      Out-Patient

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Antacid Tablet market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Antacid Tablet market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Antacid Tablet companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Antacid Tablet submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Antacid Tablet are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antacid Tablet market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now